A detailed history of Raelipskie Partnership transactions in Novo Nordisk A S stock. As of the latest transaction made, Raelipskie Partnership holds 12,618 shares of NVO stock, worth $1.1 Million. This represents 0.73% of its overall portfolio holdings.

Number of Shares
12,618
Previous 12,618 -0.0%
Holding current value
$1.1 Million
Previous $1.8 Billion 16.58%
% of portfolio
0.73%
Previous 0.96%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 18, 2024

BUY
$122.71 - $146.91 $1.55 Million - $1.85 Million
12,618 New
12,618 $1.8 Billion

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Raelipskie Partnership Portfolio

Follow Raelipskie Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raelipskie Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Raelipskie Partnership with notifications on news.